Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 37.0B | 36.3B | 36.2B | 34.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 11.9B | 10.7B | 10.6B | 10.3B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 14.3B | 12.8B | 14.7B | 14.0B |
Tax provision | 3.3B | 3.3B | 3.7B | 3.6B |
Net income | 10.9B | 9.5B | 11.0B | 10.5B |
Basic EPS | — | 3.9 | 4.5 | 4.2 |
Diluted EPS | — | 3.8 | 4.4 | 4.2 |
Basic average shares | — | 2.5B | 2.4B | 2.4B |
Diluted average shares | — | 2.5B | 2.5B | 2.5B |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | -295.4M | -71.6M | -185.5M | -199.2M |
Preferred stock dividends | — | — | — | — |